Study of Sex Differences in the Clinical Evaluation of Medical Products; Draft Guidance for Industry; Availability | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2024-D-4245

Study of Sex Differences in the Clinical Evaluation of Medical Products; Draft Guidance for Industry; Availability

Documents

Comments

Description

Open

Key Dates

Comment Period OpensJan 7, 2025

Comment Period ClosesApr 8, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Study of Sex Differences in the Clinical Evaluation of Medical Products; Guidance for Industry; Draft Guidance	Jan 7, 2025	42

Comment Statistics

Total Comments

Keywords

CDER

FRDTS # 2021-147

Study of Sex Differences in the

Clinical Evaluation of Medical Products

Draft Guidance for Industry; Availability

Open

Data from Regulations.gov